Bioharvest Sciences (BHST) Payables (2023 - 2025)

Bioharvest Sciences' Payables history runs 3 years deep, the most recent figure standing at $2.3 million for Q4 2025.

• On a quarterly basis, Payables fell 69.1% year-over-year to $2.3 million in Q4 2025; TTM through Dec 2025 was $2.3 million, a 69.1% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 69.1% from the prior year.
• Payables retreated to $2.3 million in Q4 2025 per BHST's latest filing, from $3.5 million in the prior quarter.
• Across five years, Payables topped out at $7.5 million in Q4 2024 and bottomed at $2.3 million in Q4 2023.
• The 3-year median for Payables is $3.5 million (2024), against an average of $3.9 million.
• Across the five-year window, Payables jumped 226.13% in 2024 and tumbled 69.1% in 2025, its largest moves.
• Year by year, Payables stood at $2.3 million in 2023, then soared by 226.13% to $7.5 million in 2024, then tumbled by 69.1% to $2.3 million in 2025.
• Per Business Quant, the three latest BHST Payables figures stand at $2.3 million (Q4 2025), $3.5 million (Q3 2025), and $3.4 million (Q2 2025).